Maximize the use of your software. Buy only what you need

Dec 11, 2017 | Blogs, Software, Technology | 0 comments

The latest releases of Analyst Software 1.7 and SCIEX OS Software 1.4 introduce a new licensing model called concurrent licensing. If you want flexibility and cost savings when purchasing and using your processing software, concurrent licensing is for you.

How does it work? Concurrent licenses float through the network and are passed from user to user, machine to machine. In other words, access to the software can be granted based on the number of licenses expected to be used at the same time.

So what, you ask? Good question.

The concurrent licensing model can be significantly less costly for your organization than the single device model. This means your tier 2 and tier 3 lab analyst with lower software utilization rates can now share access easily especially when access is not needed at the same time. Get a Better Understanding of Concurrent Software Licenses >

By choosing the concurrent licensing model, your organization can be more:

  • Thrifty:  Avoid overpaying for software licenses and effectively manage your software spend. Track your team’s true software consumption and easily cancel unused licenses; while share underutilized licenses within the team
  • Strategic: Simplifies administration as you can manage licenses for multiple users from one central platform and consolidate license renewal dates across your organization
  • Productive: Allows on-demand license access for local and remote teams within same time zone so users can access the software from any device within the network
  • Diligent: Ensure license compliance and eliminate the potential of costly and unexpected audit penalties

Enjoy the benefits of SCIEX software solutions and take full advantage of the flexible licensing model for your processing software.

For more questions on licensing, get in touch with our software sales specialists >

Pure and simple: Understanding LNP analytics for better mRNA-based drugs

A few years ago, it was discovered that messenger RNA (mRNA) encapsulated in lipid nanoparticles (LNPs) could result in mRNA adducts due to the breakdown products of N-oxide impurities. The ionizable lipids used in LNPs are especially susceptible to forming N-oxide impurities.

Is the next life-changing drug waiting to be analyzed in your laboratory?

In drug discovery laboratories, there is often a need to generate trusted analytical data on hundreds of thousands of drug candidates to allow confident decisions to be made. Sample prep, instrument run time, and data processing are all challenges that must be overcome.

Mass spec data across the cultivated meat value chain

We recently had the opportunity to chat with Alex Ward, PhD, Principal Consultant, Arta Bioanalytics to discover more about his work in developing transcriptomics and metabolomics data interpretation for the cultivated meat sector. As a specialist in multi-omics approaches, Alex is driving R&D, production and regulatory processes for the industry. Below are Alex’s responses to a few questions we asked, sharing his knowledge with the SCIEX community to drive the future of cultivated meat.

Posted by

0 Comments

Submit a Comment

Social Share Buttons and Icons powered by Ultimatelysocial